Hyaluronic acid: A specific prognostic indicator of hepatic damage in biliary atresia

被引:29
作者
Kobayashi, H [1 ]
Horikoshi, K [1 ]
Yamataka, A [1 ]
Yamataka, T [1 ]
Okazaki, T [1 ]
Lane, GJ [1 ]
Miyano, T [1 ]
机构
[1] Juntendo Univ, Sch Med, Dept Pediat Surg, Bunkyo Ku, Tokyo 1138421, Japan
关键词
biliary atresia; hepatic sinusoidal endothelial cell; hyaluronic acid; factor VIII-related antigen;
D O I
10.1016/S0022-3468(99)90314-7
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background/Purpose: Hepatic fibrosis can progress in biliary atresia (BA) and is associated with capillarization of hepatic sinusoids. The significance of serum hyaluronic acid (HA) as a noninvasive indicator of histological sinusoidal endothelial cell (SEC) damage and hepatic fibrosis in BA, is investigated. Methods: A total of 28 postoperative BA patients (mean age, 11.0 +/- 3.7 years) and 20 normal controls (mean age, 10.5 +/- 2.8 years) were studied. BA patients were divided into group I, good liver function (n = 8); group II, moderate liver dysfunction (n = 10); and group III, severe liver dysfunction (n = 10). Serum HA was determined using a one-step sandwich enzyme immunoassay, and liver histological damage was confirmed immunohistochemically using an antibody against factor VIII-related antigen (FVIIIRAg), which is specific for detecting damaged SEC. Results: Serum HA was significantly higher (P < .0001) in group III (84.8 +/- 80.5 ng/mL) than in group 1 (15.9 +/- 6.9 ng/mL) or group 11 (28.7 +/- 10.7 ng/mL). Although immunoreactive products of FVIIIRAg were abundant in group III, they were not detected in SEC from group II. Conclusion: Serum HA may be of value for monitoring postoperative BA patients as a noninvasive indicator of SEC damage and progressive hepatic fibrosis. J Pediatr Surg 34:1791-1794. Copyright (C) 1999 by W.B. Saunders Company.
引用
收藏
页码:1791 / 1794
页数:4
相关论文
共 16 条
  • [1] SERUM HYALURONATE AS A MARKER OF HEPATIC DERANGEMENT IN ACUTE LIVER-DAMAGE
    BRAMLEY, PN
    RATHBONE, BJ
    FORBES, MA
    COOPER, EH
    LOSOWSKY, MS
    [J]. JOURNAL OF HEPATOLOGY, 1991, 13 (01) : 8 - 13
  • [2] ASSAY OF SERUM HYALURONIC-ACID IN CLINICAL-APPLICATION
    CHICHIBU, K
    MATSUURA, T
    SHICHIJO, S
    YOKOYAMA, MM
    [J]. CLINICA CHIMICA ACTA, 1989, 181 (03) : 317 - 323
  • [3] Biliary atresia: The King's College Hospital experience (1974-1995)
    Davenport, M
    Kerkar, N
    MieliVergani, G
    Mowat, AP
    Howard, ER
    [J]. JOURNAL OF PEDIATRIC SURGERY, 1997, 32 (03) : 479 - 485
  • [4] DEACIUC IV, 1993, HEPATOLOGY, V17, P266, DOI 10.1002/hep.1840170217
  • [5] FRASER JRE, 1985, CELL TISSUE RES, V242, P505
  • [6] SERUM HYALURONATE IN LIVER-DISEASES - STUDY BY ENZYMOIMMUNOLOGICAL ASSAY
    FREBOURG, T
    DELPECH, B
    BERCOFF, E
    SENANT, J
    BERTRAND, P
    DEUGNIER, Y
    BOURREILLE, J
    [J]. HEPATOLOGY, 1986, 6 (03) : 392 - 395
  • [7] HEMODYNAMIC AND LIVER-FUNCTION PREDICTORS OF SERUM HYALURONAN IN ALCOHOLIC LIVER-DISEASE
    GIBSON, PR
    FRASER, JRE
    BROWN, TJ
    FINCH, CF
    JONES, PA
    COLMAN, JC
    DUDLEY, FJ
    [J]. HEPATOLOGY, 1992, 15 (06) : 1054 - 1059
  • [8] HARRISON RL, 1989, LIVER, V9, P242
  • [9] LIVER-TRANSPLANTATION AND KASAI OPERATION IN THE 1ST YEAR OF LIFE - THERAPEUTIC DILEMMA IN BILIARY ATRESIA
    LILLY, JR
    HALL, RJ
    ALTMAN, RP
    [J]. JOURNAL OF PEDIATRICS, 1987, 110 (04) : 561 - 562
  • [10] BIOCHEMICAL MARKERS OF HEPATIC-FIBROSIS
    PLEBANI, M
    BURLINA, A
    [J]. CLINICAL BIOCHEMISTRY, 1991, 24 (03) : 219 - 239